vs
Side-by-side financial comparison of Astera Labs, Inc. (ALAB) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.
Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($397.6M vs $270.6M, roughly 1.5× Astera Labs, Inc.). Astera Labs, Inc. runs the higher net margin — 16.6% vs 5.3%, a 11.4% gap on every dollar of revenue.
Astera Labs, Inc. is an American fabless semiconductor manufacturer and artificial intelligence company. The company specializes in designing high-speed connectivity solutions for data centers and AI infrastructure. The company has been listed on the Nasdaq since March 2024.
CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.
ALAB vs GRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $270.6M | $397.6M |
| Net Profit | $45.0M | $20.9M |
| Gross Margin | 75.6% | 21.5% |
| Operating Margin | 24.7% | 7.7% |
| Net Margin | 16.6% | 5.3% |
| Revenue YoY | 91.8% | — |
| Net Profit YoY | 82.0% | — |
| EPS (diluted) | $0.25 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $270.6M | $397.6M | ||
| Q3 25 | $230.6M | $377.4M | ||
| Q2 25 | $191.9M | $344.3M | ||
| Q1 25 | $159.4M | $329.3M | ||
| Q4 24 | $141.1M | — | ||
| Q3 24 | $113.1M | $314.4M | ||
| Q2 24 | $76.8M | — | ||
| Q1 24 | $65.3M | — |
| Q4 25 | $45.0M | $20.9M | ||
| Q3 25 | $91.1M | $9.8M | ||
| Q2 25 | $51.2M | $9.0M | ||
| Q1 25 | $31.8M | $9.4M | ||
| Q4 24 | $24.7M | — | ||
| Q3 24 | $-7.6M | $-122.0M | ||
| Q2 24 | $-7.5M | — | ||
| Q1 24 | $-93.0M | — |
| Q4 25 | 75.6% | 21.5% | ||
| Q3 25 | 76.2% | 19.8% | ||
| Q2 25 | 75.8% | 19.8% | ||
| Q1 25 | 74.9% | 19.5% | ||
| Q4 24 | 74.0% | — | ||
| Q3 24 | 77.7% | 19.4% | ||
| Q2 24 | 77.9% | — | ||
| Q1 24 | 77.4% | — |
| Q4 25 | 24.7% | 7.7% | ||
| Q3 25 | 24.0% | 4.3% | ||
| Q2 25 | 20.7% | 3.7% | ||
| Q1 25 | 7.1% | 3.9% | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | -7.9% | -33.3% | ||
| Q2 24 | -31.7% | — | ||
| Q1 24 | -127.1% | — |
| Q4 25 | 16.6% | 5.3% | ||
| Q3 25 | 39.5% | 2.6% | ||
| Q2 25 | 26.7% | 2.6% | ||
| Q1 25 | 20.0% | 2.9% | ||
| Q4 24 | 17.5% | — | ||
| Q3 24 | -6.7% | -38.8% | ||
| Q2 24 | -9.8% | — | ||
| Q1 24 | -142.5% | — |
| Q4 25 | $0.25 | — | ||
| Q3 25 | $0.50 | — | ||
| Q2 25 | $0.29 | — | ||
| Q1 25 | $0.18 | — | ||
| Q4 24 | $1.23 | — | ||
| Q3 24 | $-0.05 | — | ||
| Q2 24 | $-0.05 | — | ||
| Q1 24 | $-1.77 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.6M | $65.6M |
| Total DebtLower is stronger | — | $0 |
| Stockholders' EquityBook value | $1.4B | $217.9M |
| Total Assets | $1.5B | $412.7M |
| Debt / EquityLower = less leverage | — | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.6M | $65.6M | ||
| Q3 25 | $140.4M | $36.5M | ||
| Q2 25 | $162.3M | $18.8M | ||
| Q1 25 | $86.4M | $14.0M | ||
| Q4 24 | $79.6M | — | ||
| Q3 24 | $126.1M | $37.2M | ||
| Q2 24 | $421.1M | — | ||
| Q1 24 | $696.1M | — |
| Q4 25 | — | $0 | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $34.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.4B | $217.9M | ||
| Q3 25 | $1.3B | $195.5M | ||
| Q2 25 | $1.1B | $179.7M | ||
| Q1 25 | $1.0B | $163.2M | ||
| Q4 24 | $964.8M | — | ||
| Q3 24 | $889.6M | $133.9M | ||
| Q2 24 | $845.3M | — | ||
| Q1 24 | $808.8M | — |
| Q4 25 | $1.5B | $412.7M | ||
| Q3 25 | $1.4B | $390.0M | ||
| Q2 25 | $1.3B | $356.3M | ||
| Q1 25 | $1.1B | $334.0M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $983.1M | $348.0M | ||
| Q2 24 | $915.5M | — | ||
| Q1 24 | $864.9M | — |
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.26× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $95.3M | $34.6M |
| Free Cash FlowOCF − Capex | $76.6M | — |
| FCF MarginFCF / Revenue | 28.3% | — |
| Capex IntensityCapex / Revenue | 6.9% | — |
| Cash ConversionOCF / Net Profit | 2.12× | 1.65× |
| TTM Free Cash FlowTrailing 4 quarters | $281.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $95.3M | $34.6M | ||
| Q3 25 | $78.2M | $28.2M | ||
| Q2 25 | $135.4M | $19.9M | ||
| Q1 25 | $10.5M | $17.6M | ||
| Q4 24 | $39.7M | — | ||
| Q3 24 | $63.5M | — | ||
| Q2 24 | $29.8M | — | ||
| Q1 24 | $3.7M | — |
| Q4 25 | $76.6M | — | ||
| Q3 25 | $65.9M | $24.2M | ||
| Q2 25 | $133.3M | — | ||
| Q1 25 | $6.0M | — | ||
| Q4 24 | $24.3M | — | ||
| Q3 24 | $46.8M | — | ||
| Q2 24 | $28.5M | — | ||
| Q1 24 | $228.0K | — |
| Q4 25 | 28.3% | — | ||
| Q3 25 | 28.6% | 6.4% | ||
| Q2 25 | 69.5% | — | ||
| Q1 25 | 3.7% | — | ||
| Q4 24 | 17.2% | — | ||
| Q3 24 | 41.4% | — | ||
| Q2 24 | 37.1% | — | ||
| Q1 24 | 0.3% | — |
| Q4 25 | 6.9% | — | ||
| Q3 25 | 5.3% | 1.1% | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 10.9% | — | ||
| Q3 24 | 14.8% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 5.2% | — |
| Q4 25 | 2.12× | 1.65× | ||
| Q3 25 | 0.86× | 2.87× | ||
| Q2 25 | 2.64× | 2.21× | ||
| Q1 25 | 0.33× | 1.86× | ||
| Q4 24 | 1.61× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
